Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort

Biomedicine and Pharmacotherapy

Volumn 58, Issue 10, 2004, Pages 619-627

  Weitgasser, R ^a   Galvan, G ^a   Malaimare, L ^a   Derflinger, I ^a   Hedegger, M ^a   Lang, J ^a   Iglseder, B ^a   Ladurner, G ^a   Paulweber, B ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

HDL cholesterol; sdLDL; TaqIB CETP polymorphism

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; AUSTRIA; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ELECTROPHORESIS; FEMALE; GENOTYPE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RESTRICTION MAPPING; RESTRICTION SITE; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

EID: 13844319416     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2004.09.010     Document Type: Article

References (42)

1. E.M. Teh, P.J. Dolphin, W.C. Breckenridge, and M.H. Tan Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a caucasian subject from North America J. Lipid Res. 39 1998 442 456
2. A.R. Tall, X. Jiang, Y. Luo, and D. Silver 1999 George Lyman Duff Memorial Lecture: lipid transfer proteins, HDL metabolism, and atherogenesis Arterioscler Thromb Vasc Biol 20 2000 1185 1188
3. M.-C. Vohl, B. Lamarche, A. Pascot, G. Leroux, D. Prud'homme, and C. Bouchard Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome Int. J. Obes. 23 1999 918 925
4. I. Kawasaki, H. Tahara, M. Emoto, T. Shoji, and Y. Nishizawa Relationship between TaqIB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes Diabetes 51 2002 871 874
5. A. Durlach, C. Clavel, A. Girard-Globa, and V. Durlach Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients J. Clin. Endocrinol. Metab. 84 1999 3656 3659
6. M.E. Brousseau, J.J. O'Connor Jr., J.M. Ordovas, D. Collins, J.D. Otvos, and T. Massov Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: veterans Affairs HDL Cholesterol Intervention Trial Arterioscler Thromb Vasc Biol 22 2002 1055 1057
7. S.M. Boekholdt, J.A. Kuivenhoven, G.K. Hovingh, J.W. Jukema, J.J. Kastelein, and A. Van Tol CETP gene variation: relation to lipid parameters and cardiovascular risk Curr Opin Lipidol 15 2004 393 398
8. A.H. Klerkx, G.J. de Grooth, A.H. Zwinderman, J.W. Jukema, J.A. Kuivenhoven, and J.J. Kastelein Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS) Eur J Clin Invest 34 2004 21 28
9. J.D. Curb, R.D. Abbott, B.L. Rodriguez, K. Masaki, D.S. Sharp, and A.R. Tall A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly J Lipid Res 45 2004 948 953
10. J.D. Kark, R. Sinnreich, E. Leitersdorf, Y. Friedlander, S. Shpitzen, and G. Luc TaqIB CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol Atherosclerosis 151 2000 509 518
11. J. Vakkilainen, M. Jauhiainen, K. Ylitalo, I.O. Nuotio, J.S. Viikari, and C. Ehnholm LDL particle size in familial combined hyperlipidemia. Effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins J Lipid Res 43 2002 598 603
12. P.J. Talmud, K.L. Edwards, C.M. Turner, B. Newman, J.M. Palmen, and S.E. Humphries Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter Circulation 30 2000 2461 2466
13. B.F. Asztalos, K.V. Horvath, K. Kajinami, C. Nartsupha, C.E. Cox, and M. Batista Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency J Lipid Res 45 2004 448 455
14. D.J. Gordon, J.L. Probstfield, R.J. Garrison, J.D. Neaton, W.P. Castelli, and J.D. Knoke High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies Circulation 79 1989 8 15
15. P.J. Barter, and K.A. Rye High density lipoproteins and coronary heart disease Atherosclerosis 121 1996 1 12
16. G. Assmann, and H. Schulte Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM Experience) Am. J. Cardiol. 70 1992 733 737
17. B. Agerholm-Larsen, B.G. Nordestgaard, R. Steffensen, G. Jensen, and A. Tybjaerg-Hansen Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a mutation in the cholesteryl ester transfer protein gene Circulation 101 2000 1907 1912
18. S.V. Gelding, S. Robinson, and S. Lowe Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity Clin. Endocrinol. (Oxf.) 40 1994 611 615
19. A. Akinmokun, P.L. Selby, K. Ramaiya, and K.G.M.M. Alberti The short insulin tolerance test for determination of insulin sensitivity: A comparison with the euglycaemic clamp Diabet. Med. 9 1992 432 437
20. E. Bonora, P. Moghetti, and C. Zancanaro Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies J. Clin. Endocrinol. Metab. 68 1988 374 378
21. J.A. Kuivenhoven, J.W. Jukema, A.H. Zwinderman, P. de Knijff, R. McPherson, and A.V.G. Bruschke The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis N. Engl. J. Med. 338 1998 86 93
22. M.L. Hannuksela, M.J. Liinamaa, Y.A. Kesaniemi, and M.J. Savolainen Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers Atherosclerosis 110 1994 35 44
23. F. Fumeron, D. Betoulle, G. Luc, I. Behague, S. Ricard, and O. Poirier Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction J. Clin. Invest. 96 1995 1664 1671
24. D.J. Freeman, B.A. Griffin, A.P. Holmes, G.M. Lindsay, D. Gaffney, and T. Packard Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqIB RFLP in the CETP gene and smoking and obesity Arterioscler. Thromb. 14 1994 336 344
25. R.P. Dullaart, B.J. Beusekamp, S.C. Riemens, K. Hoogenberg, B.K. Stulp, and A. Van Tol High-density lipoprotein cholesterol is related to the TaqIB cholesteryl ester transfer protein gene polymorphism and smoking but not to moderate alcohol consumption in insulin-dependent diabetic men Scand. J. Clin. Lab. Invest. 58 1998 251 258
26. A.A. Nabulsi, A.R. Folsom, A. White, W. Patsch, G. Heiss, and K.K. Wu Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: the Atherosclerosis Risk in Communities Study Investigators N. Engl. J. Med. 328 1993 1069 1075
27. T.A. Manolio, C.D. Furberg, L. Shemanski, B.M. Psaty, D.H. O'Leary, and R.P. Tracy Associations of postmenopausal estrogen use with cardiovascular disease and ist risk factors in older women; the CHS Collaborative Research Group Circulation 88 1993 2163 2171
28. The Writing Group for the PEPI trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA 273 1995 199 208
29. S. Bernard, P. Moulin, L. Lagrost, S. Picard, M. Elchebly, and G. Ponsin Association between plasma HDL-cholesterol concentration and TaqIB CETP gene polymorphism in non-insulin-dependent diabetes mellitus J. Lipid Res. 39 1998 59 65
30. J.M. Ordovas, L.A. Cupples, D. Corella, J.D. Otvos, D. Osgood, and A. Martinez Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham Study Arterioscler Thromb Vasc Biol 20 2000 1323 1329
31. M. Arca, A. Montali, D. Ombres, E. Battiloro, F. Campagna, and G. Ricci Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis Clin Genet 60 2001 374 380
32. S. Liu, C. Schmitz, M.J. Stampfer, F. Sacks, C.H. Hennekens, and K. Lindpaintner A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men Atherosclerosis 161 2002 469 474
33. G. Eiriksdottir, M.K. Bolla, B. Thorsson, G. Sigurdsson, S.E. Humphries, and V. Gudnason The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men Atherosclerosis 159 2001 187 192
34. S. Meguro, I. Takei, M. Murata, H. Hirose, N. Takei, and Y. Mitsuyoshi Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes Atherosclerosis 156 2001 151 156
35. A. Goto, K. Sasai, S. Suzuki, T. Fukutomi, S. Ito, and T. Matsushita Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography Atherosclerosis 159 2001 153 163
36. D. Corella, C. Saiz, M. Guillen, O. Portoles, F. Mulet, and J.I. Gonzalez Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population Atherosclerosis 152 2000 367 376
37. J. Chen, T. Yokoyama, K. Saito, N. Yoshiike, C. Date, and H. Tanaka Association of human cholesteryl ester transfer protein-TaqI polymorphism with serum HDL cholesterol levels in a normolipemic Japanese rural population J Epidemiol 12 2002 77 84
38. Y. Motohashi, T. Maruyama, M. Murata, S. Nakano, C. Aruyama, and S. Kyotani Role of genetic factors (CETP gene Taq IB polymorphism and Apo A-1 gene Msp I polymorphism) in serum HDL-C levels in women Nutr Metab Cardiovasc Dis 14 2004 6 14
39. J.F. Carlquist, J.B. Muhlestein, B.D. Horne, N.I. Hart, T.L. Bair, and H.O. Molhuizen The cholesteryl ester transfer protein TaqIB gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease Am Heart J 146 2003 1007 1014
40. G.J. de Grooth, K.E. Zerba, S.P. Huang, Z. Tsuchihashi, T. Kirchgessner, and R. Belder The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy J Am Coll Cardiol 43 2004 854 857
41. R.W. Clark, T.A. Sutfin, R.B. Ruggeri, A.T. Willauer, E.D. Sugarman, and G. Magnus-Aryitey Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib Arterioscler Thromb Vasc Biol 24 2004 490 497
42. M.E. Brousseau, E.J. Schaefer, M.L. Wolfe, L.T. Bloedon, A.G. Digenio, and R.W. Clark Effects of an inhibitor if cholesteryl ester transfer protein on HDL cholesterol N Engl J Med 350 2004 1505 1515